<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04398069</url>
  </required_header>
  <id_info>
    <org_study_id>Hemodynamic optimization ICU</org_study_id>
    <nct_id>NCT04398069</nct_id>
  </id_info>
  <brief_title>Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock</brief_title>
  <official_title>Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mongi Slim Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mongi Slim Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic
      Shock, at the early phase.

      patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin
      doses:

        -  Group 1: standard hemodynamic goals and catecholamin infusion to achieve: mean arterial
           pressure &gt; or equal to 65 mmHg and diastolic arterial pressure &gt; ou equal to 50 mmHg
           within the first 60 minutes.

        -  Group 2: personalized hemodynamic goals and catecholamin infusion until normal
           transcranial doppler: IP&lt;1,2.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic
      Shock, at the early phase.

      patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin
      doses:

        -  Group 1: standard hemodynamic goals and cathecolamin infusion to achieve: mean arterial
           pressure &gt; or equal to 65 mmHg and diastolic arterial pressure &gt; ou equal to 50 mmHg
           within the first 60 minutes.

        -  Group 2: personalized hemodynamic goals and cathecolamin infusion until normal
           transcranial doppler: IP&lt;1,2.

      For the 2 groups, standard management including: microbiological sampling, early broad
      spectrum anti infective therapy, fluid management and decreasing of blood lactate levels,
      will be aimed within the first 60 minutes.

      For the Group 2 patients: personalized hemodynamic management will be maintained during 72
      hours.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality at day 28</measure>
    <time_frame>28 days after ICU admission</time_frame>
    <description>Mortality at day 28</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of sepsis associated encephalopathy</measure>
    <time_frame>28 days after ICU admission</time_frame>
    <description>sepsis associated encephalopathy assessed by CAM-ICU and GCS scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of sepsis related organ failures</measure>
    <time_frame>28 days after ICU admission</time_frame>
    <description>sepsis related organ failures assessed with SOFA score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>30 days after end of randomization</time_frame>
    <description>Length of ICU stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Trans Cranial Doppler Ultrasonography in Heamodynamic Optimisation in Septic Shock</condition>
  <arm_group>
    <arm_group_label>Standard Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard hemodynamic goals and catecholamin infusion to achieve: mean arterial pressure &gt; or equal to 65 mmHg and diastolic arterial pressure &gt; ou equal to 50 mmHg within the first 60 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>personalized hemodynamic goals Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Personalized hemodynamic goals and catecholamin infusion to achieve normal cerebral perfusion assessed by transcranial doppler: PI &lt; 1,2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hemodynamic optimisation aiming to achieve normal cerebral perfusion</intervention_name>
    <description>hemodynamic optimisation aiming to achieve normal cerebral perfusion: titration of catecholamin infusion.</description>
    <arm_group_label>personalized hemodynamic goals Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All ICU patients presenting septic shock

          -  No criteria of traumatic or vascular brain injury

        Exclusion Criteria:

          -  Patients with refractory septick shock

          -  rapid fatal evolution: before 72 hours

          -  No individualisation of the MCA ultrasonographic window
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mhamed Sami Mebazaa, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mongi Slim Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mhamed Sami Mebazaa, professor</last_name>
    <phone>0021622252589</phone>
    <email>msmebazaa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Asma Ben Souissi, Ass Prof</last_name>
    <phone>0021698336883</phone>
    <email>bsouissiasma@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mongi Slim Hospital</name>
      <address>
        <city>Tunis</city>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mhamed Sami Mebazaa, professor</last_name>
      <phone>0021622252589</phone>
      <email>msmebazaa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Asma Ben Souissi, Ass Prof</last_name>
      <phone>0021698336883</phone>
      <email>bsouissiasma@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 18, 2020</study_first_submitted>
  <study_first_submitted_qc>May 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mongi Slim Hospital</investigator_affiliation>
    <investigator_full_name>Mhamed Sami Mebazaa</investigator_full_name>
    <investigator_title>Professor head of the anesthesia and intensive care department</investigator_title>
  </responsible_party>
  <keyword>Trans cranial doppler ultrasonography, hemodynamics, septic shock, sepsis associated encephalopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

